Objective: The objective of this study was to evaluate the short-and long-term outcome after first and repeat resection in patients older than 70 years. Summary Background Data: Liver resection is the best treatment for colorectal liver metastases and is currently increasingly performed in elderly patients. The benefit of resection for these patients needs to be evaluated. Methods: Between 1990 and 2000, 56 first and 16 repeat liver resections were performed in 61 patients older than 70 years. Patients were identified from a prospective database and records were reviewed retrospectively. Results: First and repeat liver resection resulted, respectively, in a 0% and 7% postoperative mortality rate and a 41% and 38% complication rate, respectively. Median survival after first resection of 53 patients with R0 resection was 33 months, and the 5-year survival rate was 22%. Factors associated with poor long-term survival in multivariate analysis were extrahepatic disease, high carcinoembryonic antigen level over 200 ng/mL, and the presence of 3 or more liver metastases. Patients without these risk factors showed a median survival of 42 months and a 5-year survival rate of 36%. Repeat liver resection resulted in a median survival of 17 months and in a 3-year survival rate of 25%. Conclusion: First and repeat liver resection for colorectal liver metastases can be performed safely in patients older than 70 years. A 5-year survival rate similar to those of younger patients can be expected after first liver resection for patients without the presence of risk factors.
H epatic resection is the only treatment that can offer long-term survival in patients with colorectal liver metastases. [1] [2] [3] [4] Hepatic resection is a safe procedure with a mortality rate of less than 5% and a morbidity between 20% and 30%. 2,4 -7 In studies reporting resection of colorectal liver metastases, age did not appear as a risk factor influencing short-and long-term outcome. [1] [2] [3] [4] 6 Therefore, there does not exist a limit of age for resection.
Studies reporting the natural history of colorectal liver metastases revealed that 33% to 50% of all patients presenting with liver metastases were older than 70 years. 8 -10 However, in studies about resection of colorectal liver metastases, only 8% to 20% 2,7 of patients were older than 70 years. This difference may reflect a selection process favoring palliative medical treatment in the elderly. As life expectancy increases and colorectal cancer is a disease of the second part of life with an incidence increasing with age, 11 surgical treatment of colorectal liver metastases in older patients will be more frequently considered and performed. 12 The aim of this study was to evaluate the short-and long-term outcome after first and repeat hepatic resection for colorectal liver metastases in patients older than 70 years.
PATIENTS AND METHODS
This study was performed in a single institution. The medical data of 61 consecutive patients older than 70 years who underwent liver resection for colorectal liver metastases between January 1990 and December 2000 were analyzed. The routine imaging studies obtained before liver resection included computed tomography (CT) scans of the abdomen, pelvis, and chest, abdominal magnetic resonance imaging in most patients, and also a colonoscopy. Follow-up data were updated by personal contacts with patients during follow-up consultations, letters and telephone calls to referring physicians and general practitioners, and by telephone calls to the patients or their families. Patients were followed after the operation by the referring physician: oncologist, gastroenterologist, or surgeon. Our follow-up schedule included abdominal CT scan and carcinoembryonic antigen (CEA) measurements every 3 months and thoracic CT scan every 6 months during the first postoperative 2 years. After 2 years, abdominal CT scan and CEA measurements were performed every 6 months and after 5 years once a year. No patient was lost during follow up.
Primary end points were mortality, morbidity, and survival. Secondary end points were recurrence of liver metastases and appearance of other metastases.
In this series, 72 liver resections were performed in 61 patients (22 women and 39 men) with a median age of 73 years (range, 70 -81 years). Fifty-six first liver resections were performed in 56 patients. Sixteen repeat liver resections were performed in 14 patients, including 9 patients who underwent a first liver resection after 70 years and 5 patients who underwent a first liver resection before 70 years.
Medical comorbidity registered in these 61 patients is shown in Table 1 . Characteristics of patients, primary tumors, adjuvant therapy, and liver metastases are shown in Table 2 .
Adjuvant Chemotherapy First Liver Resection Group
Right portal vein embolization was performed in 7 patients before right hepatectomy, including 2 patients who underwent a 2-stage hepatectomy strategy to increase the volume of a small left liver. 13, 14 Twelve patients (21%) received chemotherapy before resection of liver metastases. Four patients received at least 2 different lines of chemotherapy and were referred to our institution after failure of chemotherapy. Eight patients had 1 line of chemotherapy each (at least 3 cycles) before liver resection (5 ϫ 5FU ϩ oxaliplatin, 2 ϫ 5FU ϩ folinic acid, 1 ϫ 5FU ϩ irinotecan); 4 patients had a partial response: 3 of them were under 5FU ϩ oxaliplatin and 1 under 5FU ϩ Irinotecan; the 4 other patients had either stabilization or progression of disease under chemotherapy. Because chemotherapy treatment was not uniformly and prospectively performed in these patients, administration of chemotherapy was not included as a prognostic factor in survival analysis.
Repeat Liver Resection Group
Right portal vein embolization was performed in 1 patient before right hepatectomy to increase the volume of a small left liver. 13 Four patients (29%) received chemotherapy before liver resection with 5FU ϩ oxaliplatin.
Type of Liver Resection
The type of hepatic resection using the recently defined international terminology 15 is shown in Table 3 . Some patients underwent more than 1 liver procedure. Annals of Surgery • Volume 240, Number 5, November 2004 Liver Resection in the Elderly
First Liver Resection Group
Hepatic pedicle lymph node dissection was performed in 39 patients (70%) and revealed positive lymph nodes in 6. Extrahepatic disease was resected and histologically confirmed in 18 patients (32%). Six patients presented with involvement of other organs by contiguous extension: diaphragm (n ϭ 3), inferior vena cava (n ϭ 1), extrahepatic portal vein (n ϭ 1), and perinephritic fascia (n ϭ 1). Discontiguous metastases occurred in 8 patients: solitary nodules of peritoneal carcinomatosis (n ϭ 6) and pulmonary metastases (n ϭ 2). Four patients presented with local recurrence of the primary tumor associated with liver metastases. Except in 2 cases of simultaneous pulmonary metastases (which were resected after the liver resection) and in 1 case associated with local recurrence of a rectal carcinoma necessitating an abdominoperineal amputation, all cases of extrahepatic disease were discovered during the laparotomy. Three patients with extrahepatic disease had microscopic (positive peritoneal cytology) or macroscopic (inferior vena cava) residual disease after surgery and were excluded from the analysis of prognostic factors. The other 53 patients could benefit from a R0 resection.
Repeat Liver Resection Group
One patient underwent 3 repeat liver resections; the others each had 1 repeat liver resection. Extrahepatic disease was resected and histologically confirmed in 5 patients (36%). Two had involvement of other organs by contiguous extension: diaphragm (n ϭ 1) and right perinephritic fascia (n ϭ 1). Discontiguous metastases occurred in 3 patients: spleen metastases (n ϭ 1) and solitary nodule of peritoneal carcinomatosis (n ϭ 2). Except for 1 case with spleen metastases, all cases of extrahepatic disease were discovered during the laparotomy. Two patients had macroscopic residual disease (tumor infiltration of hepatic pedicle, right perinephritic fascia) after surgery.
Survival rates were calculated by the method of Kaplan-Meier and were compared using the log-rank test for univariate analysis. A multivariate analysis of survival was performed using a stepwise Cox model. The level of significance was defined as a P value smaller than 0.05. All analyses were performed with the Statview software.
RESULTS

Mortality
In the group of 56 patients treated by first liver resection, mortality was 0%. In the group of 14 patients treated by 16 repeat liver resections, mortality was of 7% (n ϭ 1). The overall mortality for first and repeat resection was 1.6%. The only death occurred at the second postoperative day and was caused by congestive heart failure in a patient 71 years of age. This woman had a history of hypokinetic cardiomyopathy, which was responsible of acute pulmonary edema 7 years before liver surgery. Preoperative cardiac evaluation showed a cardiac output of 45% and the patient was under antiarrhythmic medication (Amiodarone).
Morbidity
Postoperative course was uneventful in 34 patients (59%) who had a first liver resection. Thirty-six complications occurred postoperatively in 22 patients and are listed in Table 4 . Major complications included 3 surgical complications requiring reoperation and 3 medical complications (respiratory insufficiency, unstable angina, pulmonary embolism).
In 14 patients undergoing 16 repeat liver resections, the postoperative course was uneventful in 10 patients (62%). No major complication was registered. No patient required reop- 
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Overall Survival
Forty patients had died at the time of the last follow up with a median survival time from liver resection of 21 months (range, 2-56 months). The median follow up of the 21 survivors was 34 months (range, 24 -114 months). Ten of them were disease-free at the last follow up with a median follow up of 45 months (range, 26 -114 months). Among them, 1 patient underwent a resection of a solitary pulmonary metastasis 29 months after liver resection and 85 months before the last follow up.
Overall survival for all 56 patients with first liver resection was, respectively, 86% at 1 year, 57% at 2 years, 44% at 3 years, and 21% at 5 years. Median overall survival was 28 months. Overall survival for the 53 patients with R0 first liver resection was 87% at 1 year, 58% at 2 years, 47% at 3 years, and 22% at 5 years. Median overall survival was 33 months. Risk factors for poor overall survival found in an univariate analysis ( Table 5 ) were presence of 3 or more liver metastases and a tumor size larger than 5 cm. In a multivariate analysis, a high preoperative CEA level over 200 ng/mL and presence of 3 or more liver metastases were independent risk factors for poor overall survival ( Table 6 ).
Recurrent Disease and Disease-Free Survival
Among 53 patients with R0 first liver resections, 42 patients developed recurrent disease: 30 within the liver (9 patients had repeat resection), 10 with lung metastases, 6 with peritoneal metastases, 2 with lymph node metastases (iliac and cervical), 2 with bone metastases, and 2 with local recurrences (some patients had more than 1 localization of recurrent disease). Eleven patients did not develop any recurrence: no liver metastases and no extrahepatic metastases.
Disease-free survival was 45% at 1 year, 23% at 2 years, and 19% at 3 and 5 years. Median disease-free survival was 12 months. Risk factors for recurrence found in an univariate analysis of disease-free survival ( Table 5) were presence of extrahepatic disease and presence of 3 or more liver metastases. In a multivariate analysis, presence of extrahepatic disease, presence of 3 or more liver metastases, and a high preoperative CEA level over 200 ng/mL were independent risk factors for recurrence and poor disease-free survival ( Table 6 ). The 3 patients without R0 resection died, respectively, at 6, 22, and 25 months after liver surgery as a result of disease progression.
Resection of recurrent liver metastases, after exclusion of perioperative mortality (n ϭ 1), resulted in a median survival of 17 months (range, 2-46 months) and a mean survival of 19 months. The 1-, 2-, and 3-year survival rates were 61%, 37%, and 25%, respectively. There was no survivor at 5 years. All patients developed recurrence within 3 years.
Prognostic Factors
The influence on survival and disease-free survival of 3 independent risk factors, which were shown to be significant in multivariate analysis (presence of extrahepatic disease, presence of 3 or more liver metastases, and a high preoperative CEA level over 200 ng/mL), was studied according to the number of risk factors present in each patient (Fig. 1) . Patients without these risk factors (n ϭ 21) presented a 3-and 5-year overall survival of 59% and 36% and a median overall survival of 42 months. Three-and 5-year disease-free survival was 33%. With 1 risk factor (n ϭ 22), 3-year overall survival was 47% and median overall survival was 33 months. Three-year disease-free survival was 14%. With 2 or 3 risk factors (n ϭ 10), the 3-year overall survival was 20% and median overall survival was 14 months. All patients had recurrence within the first year (P Ͻ 0.0001). 
DISCUSSION
This study provides further evidence that resection of colorectal liver metastases in elderly patients can be performed with a very low mortality and an acceptable morbidity. These results suggest that liver resections for colorectal liver metastases are justified in the elderly because they offer, like in younger patients, the only chance for cure, compared with untreated patients who have a median survival of 4.5 to 6.5 months 8, 16 or with patients treated by chemotherapy alone who have a median survival of 9.2 to 16.5 months. 16 -18 As previously advocated, the only contraindication for liver resection is the technical nonfeasibility of the hepatectomy, independently of the presence of poor prognostic factors. 1, 19 However, the presence or absence of poor prognostic factors is influencing the long-term outcome. In this study, the best candidates for liver resection were patients with 1 or 2 liver metastases with a CEA level less than 200 ng/mL and without extrahepatic disease.
Most studies about liver resection in the elderly reported resection of hepatocellular carcinoma 20, 21 and also a variety of primary and secondary liver tumors as well as benign disease. 22, 23 Studies analyzing specifically results for resection of colorectal liver metastases in elderly patients over 70 years 24 -29 included various numbers of patients (18 -128) . The present series is the second largest on this topic.
In this study, a low mortality rate of 1.6% was registered. Mortality was 0% in the group of first liver resections and 7% (n ϭ 1) in the group of repeat resections. Morbidity was, respectively, 41% and 38% for first and repeat liver resections. Recent studies have shown a similar mortality rate of 4% to 7% and a morbidity rate of 28% to 42%. [25] [26] [27] [28] [29] A less recent study showed a morbidity of 50% and a mortality increasing with the age of patients and reaching 11% in those over 64 years. 24 Overall median survival after first liver resection of 28 months (33 months after R0 resection) in the present series was similar to median survival times (18 -40 months) previously reported. 25, 27, 28 Multivariate analysis identified a high preoperative CEA level over 200 ng/mL, the presence of 3 or more liver metastases, and extrahepatic disease as risk factors for recurrence and poor survival after first liver resection. These risk factors have also been identified in some other series. [2] [3] [4] 6, 7, 19 Patients without these risk factors (n ϭ 21) had a 5-year overall survival rate of 36% and a 5-year disease-free survival rate of 33%, similar to those reported for younger patients. 2,4 -6,19 In our institution, the presence of extrahepatic disease discovered during laparotomy is not a contraindication to liver resection provided that these lesions are localized and completely resectable. In the present study, patients with extrahepatic disease presented a median overall survival of 17 months, a 3-year overall survival of 40%, and a 3-year disease-free survival of 7% (Table 5 ). Untreated patients with colorectal liver metastases and extrahepatic disease have a median survival of 6.4 months and a 3-year survival of 1%, 30 whereas for patients treated following the latest regimens of chemotherapy, a median survival of 9.2 to 16.5 months was reported. 16 -18 In studies reporting resection of liver metastases associated with localized extrahepatic disease for patients with colorectal cancer, extrahepatic disease appeared, like it appears in the present series, as a risk factor for long-term survival. However, a 5-year survival rate of 18% to 27% was reported for these patients. 2, 4, 31 These data and our experience suggest that long-term survival is possible after resection of colorectal liver metastases and localized extrahepatic disease in selected patients. However, only a randomized, prospective trial could show that this strategy will be of benefit for the patients. Hepatic pedicle lymph node involvement has been studied in our institution and was shown to be a significant factor of poor prognosis. 32 The importance of patient selection for survival after hepatectomy is illustrated by studies using 18 FDG positron emission tomography for preoperative evaluation of liver metastases, extrahepatic disease, and resectability. In 1 study, a 3-year survival rate of 77% (95% confidence limit, 60 -94%) was reported. 33 These excellent results are the result of selection of patients for surgery, excluding those with extrahepatic disease from resection.
The present study is, to our knowledge, the first that reports results of repeat liver resection in patients over 70 years. Recurrent disease appeared in 79% of patients undergoing a R0 first liver resection, a rate which is similar to results of 66% to 71% observed by other authors. 27, 34 Our results suggest that a rather aggressive strategy (50% major resections in the group of repeat resection) can be performed with a low mortality and an acceptable morbidity. However, the long-term benefit for the individual patient is more questionable because there was no survivor after 5 years in this group; all patients had recurrence within 3 years. In this study, 5 patients (36%) had extrahepatic disease, which was a risk factor for recurrence and for poor disease-free survival after first liver resection. However, the mean survival time of 19 months after repeat liver resection in elderly patients in the present study was similar to a mean survival time of 16 months for 14 patients with hepatic and extrahepatic recurrences and to a mean survival time of 20 months for 115 patients with recurrence limited to the liver reported in a French multicenter study for patients with a mean age of 59 years. 35 Thus, these data cannot provide a definitive answer to the question of whether repeat liver resection should be performed in elderly patients. However, it should be performed only in patients without risk factors for recurrence and particularly without extrahepatic disease. An alternative to surgical resection for this group of patients could be percutaneous radiofrequency ablation. 36 However, this procedure needs further evaluation.
In conclusion, our study provides further evidence that hepatic resection for colorectal liver metastases in elderly patients can be performed with similar short-and long-term outcome compared with younger patients. Therefore, first liver resection in the elderly is justified when a chance for a curative resection can be offered, irrespective of the presence of poor prognostic factors. At the opposite end of the spectrum, repeat liver resection for elderly patients remains controversial. Therefore, indications for repeat resection should be considered very selectively, and percutaneous local destruction by radiofrequency could be a good alternative to surgery for this group of patients.
